PDB24 LONG-TERM CLINICAL AND COST OUTCOMES OF TREATMENT WITH INSULIN DETEMIR PLUS INSULIN ASPART IN TYPE I DIABETES PATIENTS IN THE CZECH SETTING; DATA FROM THE PREDICTIVE STUDY